Target intelligence / Profile preview

Intraocular bacteria

Molecular classification
Other (Pathogenic Bacteria)
01

Overview

Intraocular bacteria refer to a diverse group of pathogenic microorganisms that infiltrate the internal structures of the eye, primarily the vitreous and aqueous humors (StatPearls, 2023). This infiltration typically leads to endophthalmitis, a severe inflammatory condition that can result in permanent vision loss if not treated urgently (PubMed, 2022). Common causative agents include Gram-positive species like Staphylococcus epidermidis and Staphylococcus aureus, as well as Gram-negative organisms such as Pseudomonas aeruginosa (NIH, 2021). Therapeutic intervention involves the administration of broad-spectrum antibiotics, often via intravitreal injection, to eliminate the pathogens and mitigate the host's inflammatory response (AAO, 2023). While the bacteria themselves are the focus of treatment, they represent a biological category rather than a single molecular target (Journal of Ophthalmic Inflammation and Infection, 2020).

Other names
Ocular pathogensEndophthalmitis-causing bacteriaIntraocular pathogensOcular bacterial flora
02

Mechanism of action

Inhibition of bacterial cell wall synthesis (glycopeptides and cephalosporins), inhibition of protein synthesis (aminoglycosides), and inhibition of DNA gyrase and topoisomerase IV (fluoroquinolones).

03

Biological functions

PathogenesisInfectionBiofilm formationHost immune evasion
04

Disease associations

InfectionEndophthalmitisUveitisKeratitisPanophthalmitis
05

Safety considerations

Retinal toxicity (especially with aminoglycosides)Antibiotic resistance (e.g., MRSA, MRSE)Intraocular inflammation/uveitisRisk of retinal detachment or hemorrhage from intravitreal injection
06

Interacting drugs

Vancomycin

6 more in the full profile.

07

Biomarkers

16S rRNA PCRVitreous cultureAqueous humor analysisGram stainMatrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry

Beyond the preview

Go deeper on Intraocular bacteria.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intraocular bacteria.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call